Akebia Therapeutics Q3 EPS $(0.46) Misses $(0.43) Estimate, Sales $91.98M Miss $99.38M Estimate

Akebia Therapeutics (NASDAQ:AKBA) reported quarterly losses of $(0.46) per share which missed the analyst consensus estimate of $(0.43) by 6.98 percent. This is a 23.33 percent increase over losses of $(0.6) per share

Benzinga · 11/12/2019 13:00

Akebia Therapeutics (NASDAQ:AKBA) reported quarterly losses of $(0.46) per share which missed the analyst consensus estimate of $(0.43) by 6.98 percent. This is a 23.33 percent increase over losses of $(0.6) per share from the same period last year. The company reported quarterly sales of $91.98 million which missed the analyst consensus estimate of $99.38 million by 7.45 percent. This is a 73.00 percent increase over sales of $53.169 million the same period last year.